Related Experiment Videos
Inflammatory bowel disease in the elderly. Practical treatment guidelines
1Department of Gastroenterology, University of San Francisco Medical Center, California, USA.
Drugs & Aging
|March 1, 1997
Summary
Inflammatory bowel disease (IBD) increasingly affects older adults, presenting diagnostic challenges due to overlapping symptoms with other conditions. Treatment guidelines emphasize topical agents, oral medications, and immunomodulators, considering patient comorbidities for effective management.
Area of Science:
- Gastroenterology
- Geriatric Medicine
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is increasingly diagnosed in elderly populations.
- New-onset IBD in individuals in their seventh and eighth decades of life presents unique clinical considerations.
Purpose of the Study:
- To review and outline practical treatment guidelines for elderly patients with IBD.
- To address the diagnostic challenges and management strategies specific to IBD in older adults.
Main Methods:
- Review of current medical literature and treatment protocols for IBD.
- Analysis of therapeutic approaches considering age-related factors and comorbidities.
Main Results:
- Diagnosis of IBD in the elderly can be challenging due to potential confusion with infectious, ischemic, drug-related processes, diverticulitis, and carcinoma.
- Treatment strategies are similar to younger patients but require careful consideration of comorbid illnesses.
- Recommended therapies include topical agents for distal disease, oral mesalazine or sulfasalazine for maintenance, corticosteroids for active disease, metronidazole for colonic Crohn's disease, and immunomodulators for refractory cases.
Conclusions:
- Tailored treatment approaches are essential for managing IBD in the elderly.
- Early and accurate diagnosis, alongside consideration of comorbidities, improves therapeutic outcomes in older IBD patients.